Search
Halozyme Therapeutics Inc
HALOAdd to Watchlist
68.550USD
-0.020-0.03%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
8.13BMarket Cap
23.19P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Royalties
867.84M
62.14%
Sales of proprietary products
194.61M
13.93%
Sales of bulk rHuPH20
133.02M
9.52%
Sales-based milestones
70.00M
5.01%
Sales of device partnered products
48.81M
3.50%
Other
82.33M
5.89%
By RegionUSD
Name
Revenue
Proportion
United States
822.98M
58.93%
Switzerland
276.41M
19.79%
Belgium
217.52M
15.57%
Japan
46.37M
3.32%
All other foreign
33.33M
2.39%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Royalties
867.84M
62.14%
Sales of proprietary products
194.61M
13.93%
Sales of bulk rHuPH20
133.02M
9.52%
Sales-based milestones
70.00M
5.01%
Sales of device partnered products
48.81M
3.50%
Other
82.33M
5.89%
